Skip to content
中文产业新闻精选评分63Chinese source

BioNTech/OncoC4新一代CTLA-4抗体gotistobart经治鳞状NSCLC三期mOS提升近一倍

BioNTech/OncoC4：新一代CTLA-4抗体用于经治sqNSCLC，mOS提升近一倍

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.